Inversely, CD4+ T cell effector responses were significantly increased in the tumor and tumor-draining lymph node of CD19Cre/+; Myd88Fl/Fl mice and unaltered in the spleen (Figures 3C–E). This evidence concerns the gene CD4 and neoplasm.